News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Biosimilars

Latest News

May 30th 2017

The Importance of Real-World Data in Type 2 Diabetes

Understanding the DUAL VII Findings in Type 2 Diabetes

Impact of Cardiovascular Data in Type 2 Diabetes

Access to Therapeutic Combinations in Type 2 Diabetes

Hypoglycemia: An Unrecognized Complication in Diabetes

Latest Videos

The Future of Healthcare in the United States

The Future of Healthcare in the United States

How Will an ACA Repeal Affect Healthcare?

How Will an ACA Repeal Affect Healthcare?

The Politics of Healthcare Reform

The Politics of Healthcare Reform

Navigating Eligibility and Access Issues When Diagnosed

Navigating Eligibility and Access Issues When Diagnosed

The Balancing Act of Cost vs Access to Care

The Balancing Act of Cost vs Access to Care

Role of Health Plans in Medicaid Expansion

Role of Health Plans in Medicaid Expansion

ACA, Medicaid Expansion, and Cancer Care

ACA, Medicaid Expansion, and Cancer Care

ACA: Effect on Patients With Chronic Conditions

ACA: Effect on Patients With Chronic Conditions

Influence of Value Frameworks in Clinical Practice

Influence of Value Frameworks in Clinical Practice

Using Reimbursement Models to Overcome Oncology Care Gaps

Using Reimbursement Models to Overcome Oncology Care Gaps

More News

Clinical Evidence of Insulin Degludec in Type 2 Diabetes

May 30th 2017

Formulary Access to Insulins in Type 2 Diabetes

May 30th 2017

Deciding Among Insulin Therapies for Type 2 Diabetes

May 30th 2017

Practical Decisions in Type 2 Diabetes

May 30th 2017

Barriers to Insulin Therapy in Type 2 Diabetes

May 30th 2017

Role of GLP-1/Insulin Combinations

May 30th 2017

Formulary Decisions and GLP-1/Insulin Combinations

May 30th 2017

Cardiovascular Considerations in Antidiabetic Therapies

May 30th 2017

Appropriate Access: Payer Perspective on Newer Insulins

May 30th 2017

Evidence With Ultra–Long Acting Insulins

May 30th 2017

Barriers to Traditional Insulin Therapy

May 30th 2017

Formulary Management: Antidiabetes Medications

May 30th 2017

Juggling Multiple Factors When Selecting Therapy

May 30th 2017

Adherence Matters When Weighing a Single Injection

May 30th 2017

The Advantages of Insulin, GLP-1 Combinations

May 30th 2017

Glycemic Control Is the Bottom Line

May 30th 2017

Formulary Decisions and Clinical Practice

May 30th 2017

Understanding Factors Behind Insulin Costs

May 30th 2017

Comparing New Insulins to Older Formulations

May 30th 2017

When to Start Insulin? Lack of Consensus on Targets

May 30th 2017

Selecting Therapy to Meet Individual Needs

May 30th 2017

Developing Appropriate Quality Measures in Oncology

May 10th 2017

Capturing Meaningful Measures in Cancer

May 10th 2017

Realizing Patient Goals in Cancer Care

May 10th 2017

Keeping Oncology Care Patient-Centered

May 10th 2017

Trending on AJMC

ICYMI: Highlights From ASH 2025

Top 5 Most-Read Dermatology Content of 2025

Top 5 Most-Read Reimbursement Content of 2025

Top 5 Most-Read "5 Things" Articles of 2025

Visibility, Not Lesion Burden, Drives Distress in Alopecia Areata

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.